Phase 1/2Not yet recruiting
Evaluating Autologous Platelet-Rich Fibrin Plasma for Chronic Lower Extremity Ulcers
A Multi-Center, Prospective, Open-label Study Evaluating Autologous Platelet-Rich Fibrin Plasma for Chronic Lower Extremity Ulcers
- Sponsor
- Tiger Biosciences, LLC. (Industry)
- Enrolment
- 30 planned
- Conditions
- Lower Extremity; Chronic Ulcers; Pressure Ulcer (PU); Venous Leg Ulcer (VLU); Wound Management
- Interventions
- PRFM
- Ages
- adults, older adults
- Registry
- NCT07862335
Full record on ClinicalTrials.gov
From the registry
To prospectively evaluate the safety and efficacy of an Autologous Platelet-Rich Fibrin Plasma system when applied in conjunction with Standard of Care for management of chronic lower extremity wounds.
Primary outcomes
- Prospective assessment of wound closure
History
Primary completion expected
Registered
Started